ATE193446T1 - Verwendung von triazinverbindungen bei angstzuständen - Google Patents

Verwendung von triazinverbindungen bei angstzuständen

Info

Publication number
ATE193446T1
ATE193446T1 AT94909264T AT94909264T ATE193446T1 AT E193446 T1 ATE193446 T1 AT E193446T1 AT 94909264 T AT94909264 T AT 94909264T AT 94909264 T AT94909264 T AT 94909264T AT E193446 T1 ATE193446 T1 AT E193446T1
Authority
AT
Austria
Prior art keywords
anxiety
triazine compounds
triazine
compounds
Prior art date
Application number
AT94909264T
Other languages
English (en)
Inventor
Martyn Alan Edwin Critchley
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE193446T1 publication Critical patent/ATE193446T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94909264T 1993-03-19 1994-03-18 Verwendung von triazinverbindungen bei angstzuständen ATE193446T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305692A GB9305692D0 (en) 1993-03-19 1993-03-19 Therapeutic triazine compounds and use
PCT/GB1994/000560 WO1994021261A1 (en) 1993-03-19 1994-03-18 Use of triazine compounds as anxiolytics

Publications (1)

Publication Number Publication Date
ATE193446T1 true ATE193446T1 (de) 2000-06-15

Family

ID=10732357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909264T ATE193446T1 (de) 1993-03-19 1994-03-18 Verwendung von triazinverbindungen bei angstzuständen

Country Status (17)

Country Link
US (1) US5658905A (de)
EP (1) EP0689440B1 (de)
JP (1) JP3633618B2 (de)
AP (1) AP464A (de)
AT (1) ATE193446T1 (de)
AU (1) AU6217794A (de)
CY (1) CY2248B1 (de)
DE (1) DE69424779T2 (de)
DK (1) DK0689440T3 (de)
ES (1) ES2147232T3 (de)
GB (1) GB9305692D0 (de)
GR (1) GR3033941T3 (de)
IL (1) IL109035A0 (de)
PH (1) PH31255A (de)
PT (1) PT689440E (de)
WO (1) WO1994021261A1 (de)
ZA (1) ZA941939B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
WO2009093774A1 (en) * 2008-01-23 2009-07-30 Korea Institute Of Science And Technology Method for treatment of anxiety disorder by regulating t-type calcium channel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA803250B (en) * 1979-06-01 1982-01-27 Wellcome Found Substituded aromatic compounds
DE4118740A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue kombinationspraeparate zur behandlung des morbus parkinson

Also Published As

Publication number Publication date
DE69424779D1 (de) 2000-07-06
JPH08507783A (ja) 1996-08-20
AP464A (en) 1996-02-20
PT689440E (pt) 2000-10-31
EP0689440A1 (de) 1996-01-03
WO1994021261A1 (en) 1994-09-29
PH31255A (en) 1998-06-18
DK0689440T3 (da) 2000-10-30
ES2147232T3 (es) 2000-09-01
US5658905A (en) 1997-08-19
EP0689440B1 (de) 2000-05-31
CY2248B1 (en) 2003-07-04
ZA941939B (en) 1995-09-18
DE69424779T2 (de) 2000-11-02
AU6217794A (en) 1994-10-11
JP3633618B2 (ja) 2005-03-30
IL109035A0 (en) 1994-06-24
GB9305692D0 (en) 1993-05-05
GR3033941T3 (en) 2000-11-30
AP9400628A0 (en) 1994-04-30

Similar Documents

Publication Publication Date Title
DE69431880D1 (de) Verwendung von (2-imidazolin-2-yl-amino) quinoxalinderivaten
DE59309479D1 (de) Verwendung von detergensgemischen
DK154192D0 (da) Heterocycliske forbindelser
ATE135733T1 (de) Quasi-azeotrope mischungen zur verwendung als kältemittel
DE69636313D1 (de) Verwendung von Kristallformen von 2-Methylthienobenzodiazepinen
DE69308305D1 (de) Verwendung von zeoliten bei der umsetzung von sauerstoffverbindungen in kohlenwasserstoffen
DK187691A (da) Fremgangsmaade til nyttiggoerelse af affaldsgods
DE69220382D1 (de) Verwendung von Peptidderivaten
KR950700276A (ko) 헤테로고리 화합물(heterobicyclic compounds)
DE69228502D1 (de) Phthalocyaninverbindungen und ihre Verwendung
DE69422892D1 (de) Verwendung von halbleitergassensoren
DE69330971D1 (de) Ablauffolgeplanung der Modusänderungen bei diskreten Auftragselementen
DE69326052D1 (de) Verwendung von dieselschmierstoffe
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
DE59209936D1 (de) Verwendung von Acetalen
EE9400420A (et) Indenoindoolühendite kasutamine
ATE90508T1 (de) Verwendung von di-styryl-phenyl-triglykolether als kristallisationsinhibitor.
DK0642506T3 (da) Heterocyclisk disubstituerede sulfonaminocarbonylforbindelser
DE69513864D1 (de) Verwendung von Polyketon /HDPE Mischungen
ATE193446T1 (de) Verwendung von triazinverbindungen bei angstzuständen
DE59702736D1 (de) Verwendung von textilausrüstungsmitteln
DE59401861D1 (de) Verwendung von ferrocen
DE59204051D1 (de) Verwendung von polymodalem beta-Oktogen.
NO933170D0 (no) Heterocykliske forbindelser
DE69024524D1 (de) Substituierte Tetrahydroindanderivate und ihre Verwendung als Zwischenprodukte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee